Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-17
Publisher
IOS Press
Online
2019-01-23
DOI
10.3233/jad-180539
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkers
- (2018) Yaping Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease
- (2018) Paul M. McKeever et al. MOLECULAR NEUROBIOLOGY
- Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
- (2018) Sylvain Lehmann et al. Frontiers in Aging Neuroscience
- MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
- (2018) Takehiro Kiko et al. JOURNAL OF ALZHEIMERS DISEASE
- Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways
- (2017) John P. Cogswell et al. JOURNAL OF ALZHEIMERS DISEASE
- Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study
- (2016) Mareike Müller et al. JOURNAL OF ALZHEIMERS DISEASE
- MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease
- (2016) Theresa A. Lusardi et al. JOURNAL OF ALZHEIMERS DISEASE
- MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
- (2015) Johannes Denk et al. PLoS One
- Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
- (2013) C. Sala Frigerio et al. NEUROLOGY
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- MicroRNAs as biomarkers for CNS disease
- (2013) Pooja Rao et al. Frontiers in Molecular Neuroscience
- Effect of Mild Cognitive Impairment and APOE Genotype on Resting Cerebral Blood Flow and its Association with Cognition
- (2012) Christina E Wierenga et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future
- (2011) Roberta Ghidoni et al. Neurodegenerative Diseases
- Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells
- (2011) Yuan Yuan Li et al. NEUROSCIENCE LETTERS
- Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models
- (2010) Y.Y. Li et al. NEUROSCIENCE LETTERS
- Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression
- (2010) A. Git et al. RNA
- An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells
- (2008) Walter J. Lukiw et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started